FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Nurtec ODT (rimegepant sulfate) from Pfizer, indicating a labeling change related to this migraine medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• NURTEC ODT (RIMEGEPANT SULFATE)

Snippet

SUPPL AP for NURTEC ODT (RIMEGEPANT SULFATE)